Business
Biogen Will Begin Screening Patients in May for a Four-year Study Aimed at Confirming the ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Biogen will begin screening patients in May for a four-year study aimed at confirming the effectiveness of Aduhelm, the company’s controversial Alzheimer’s medicine ...'
Biogen will begin screening patients in May for a four-year study aimed at confirming the effectiveness of Aduhelm, the company’s controversial Alzheimer’s medicine https://t.co/0rqVGZ4Kn2— Bloomberg (@business) March 30, 2022
(The above story first appeared on LatestLY on Mar 30, 2022 08:41 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
